Page 9 - Rapid Micro News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Rapid Micro Biosystems Announces Pricing of Initial Public Offering Rapid Micro Biosystems, Inc. Lowell, Massachusetts, UNITED STATES LOWELL, Mass., July 14, 2021 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (“Rapid Micro”), an innovative life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products, today announced the pricing of its initial public offering of 7,920,000 shares of its Class A common stock at a price to the public of $20.00 ...

15 jul 2021 Rapid Micro Biosystems Announces Pricing of Initial Public Offering LOWELL, Mass., July 14, 2021 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (“Rapid Micro”), an innovative life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products, today announced the pricing of its initial public offering of 7,920,000 shares of its Class A common stock at a price to the public of $20.00 per share. All of the shares of Class A common stock are being offered by Rap...

Rapid Micro Biosystems, Inc.: Rapid Micro Biosystems Announces Pricing of Initial Public Offering LOWELL, Mass., July 14, 2021 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) ("Rapid Micro"), an innovative life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products, today announced the pricing of its initial public offering of 7,920,000 shares of its Class A common stock at a price to the public of $20.00 per share. All of the shares of Class A common stock are being of...

(1) LOWELL, Mass., March 16, 2021 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc., the leading provider of data integrity and automation technology for microbial detection in biopharmaceutical manufacturing, today announced the completion of an $81 million equity financing. The funding round was led by new investor D1 Capital Partners, along with funds and accounts managed by BlackRock, funds and accounts advised by T. Rowe Price Associates, Inc., Adage Capital Management, Sunley House Capital Management, and CaaS Capital Management. These new investors join an existing investor group that...

Share this article Share this article ResearchAndMarkets.com's offering. This report provides reliable estimates and real-world forecasts for the In Vitro diagnostics industry for two decades. In its latest report the analyst estimates the market for In Vitro diagnostic products, including instruments, reagents and associated supplies to be $83.3 billion dollars. This is a substantial increase over our 2019 estimates, with 9 billion dollars of revenue originating from molecular and antibody COVID-19 testing responsible for most of the growth. Other infectious diseases (particularly respirator...